Evofem Biosciences (EVFM)
Evofem Biosciences on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on OTC, classified by the SEC as pharmaceutical preparations.
5K
Short interest
settlement 2026-10-15
1.0
Days to cover
unchanged vs prior
55.2%
Short share of volume
2022-08-10
11,618
Fails to deliver
settlement 2026-06-17
Thu 12 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-15.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in EVFM is 4,845 shares, down 6,404 shares over the last month. Over the last 48 readings it ranged from 200 shares (31 July 2025) to 130,506 shares (13 June 2025). The latest reading sits at the bottom of that range. At the reported average volume of 283K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/evfm" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 4,845 | -51.8% | 282,680 | 1.00 |
| 2026-09-30 | 10,049 | -10.7% | 145,753 | 1.00 |
| 2026-09-15 | 11,249 | -61.9% | 365,085 | 1.00 |
| 2026-08-31 | 29,497 | +4.4% | 557,159 | 1.00 |
| 2026-08-14 | 28,248 | +7143.1% | 370,435 | 1.00 |
| 2026-07-31 | 390 | -96.6% | 303,015 | 1.00 |
| 2026-07-15 | 11,322 | +31.8% | 781,663 | 1.00 |
| 2026-06-30 | 8,590 | +356.7% | 486,778 | 1.00 |
| 2026-06-15 | 1,881 | -88.9% | 641,624 | 1.00 |
| 2026-05-29 | 16,924 | +8362.0% | 311,130 | 1.00 |
| 2026-05-15 | 200 | -87.5% | 664,781 | 1.00 |
| 2026-04-30 | 1,595 | +697.5% | 681,028 | 1.00 |
| 2026-04-15 | 200 | -99.3% | 113,170 | 1.00 |
| 2026-03-31 | 29,455 | +321.0% | 175,751 | 1.00 |
| 2026-03-13 | 6,997 | +3398.5% | 317,692 | 1.00 |
| 2026-02-27 | 200 | -97.2% | 165,073 | 1.00 |
| 2026-02-13 | 7,034 | -2.7% | 413,284 | 1.00 |
| 2026-01-30 | 7,232 | -36.2% | 592,327 | 1.00 |
| 2026-01-15 | 11,335 | -50.4% | 252,746 | 1.00 |
| 2025-12-31 | 22,871 | -9.9% | 1,399,991 | 1.00 |
| 2025-12-15 | 25,387 | -0.3% | 408,435 | 1.00 |
| 2025-11-28 | 25,452 | +80.2% | 381,188 | 1.00 |
| 2025-11-14 | 14,126 | -52.5% | 893,668 | 1.00 |
| 2025-10-31 | 29,727 | +228.2% | 1,348,590 | 1.00 |
| 2025-10-15 | 9,059 | -35.8% | 1,368,459 | 1.00 |
| 2025-09-30 | 14,117 | -88.5% | 1,582,488 | 1.00 |
| 2025-09-15 | 122,951 | +629.5% | 1,404,201 | 1.00 |
| 2025-08-29 | 16,853 | +5517.7% | 828,204 | 1.00 |
| 2025-08-15 | 300 | +50.0% | 651,301 | 1.00 |
| 2025-07-31 | 200 | -99.8% | 563,205 | 1.00 |
| 2025-07-15 | 123,082 | +330.0% | 447,032 | 1.00 |
| 2025-06-30 | 28,625 | -78.1% | 529,984 | 1.00 |
| 2025-06-13 | 130,506 | +137.2% | 691,958 | 1.00 |
| 2025-05-30 | 55,014 | +12576.0% | 807,421 | 1.00 |
| 2025-05-15 | 434 | +0.0% | 430,632 | 1.00 |
| 2025-04-30 | 434 | -98.2% | 274,336 | 1.00 |
| 2025-04-15 | 24,003 | +2.7% | 689,779 | 1.00 |
| 2025-03-31 | 23,364 | -64.5% | 1,384,055 | 1.00 |
| 2025-03-14 | 65,908 | -29.2% | 873,926 | 1.00 |
| 2025-02-28 | 93,105 | +950.3% | 2,267,839 | 1.00 |
| 2025-02-14 | 8,865 | -41.0% | 735,020 | 1.00 |
| 2025-01-31 | 15,013 | -61.1% | 1,085,079 | 1.00 |
| 2025-01-15 | 38,595 | -48.5% | 1,007,141 | 1.00 |
| 2024-12-31 | 74,920 | +126.6% | 844,163 | 1.00 |
| 2024-12-13 | 33,066 | -30.9% | 772,370 | 1.00 |
| 2024-11-29 | 47,843 | +1655.1% | 1,359,129 | 1.00 |
| 2024-11-15 | 2,726 | -96.6% | 1,878,267 | 1.00 |
| 2024-10-31 | 79,317 | +41.6% | 982,744 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 10 August 2022, the short share of EVFM volume is 55.2%, up 3.7 points over the last five sessions. Over the last 30 readings it ranged from 38.7% (2 August 2022) to 60.9% (27 July 2022). The latest reading is 4.2 points above the 30-session average of 51.0%, on 29.8M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2022-08-10 | 16.5M | 29.8M | 55.2% | 811,556 |
| 2022-08-09 | 7.9M | 15.2M | 51.9% | 616,732 |
| 2022-08-08 | 6.2M | 12.0M | 51.8% | 685,465 |
| 2022-08-05 | 11.1M | 23.0M | 48.4% | 412,492 |
| 2022-08-04 | 4.8M | 8.3M | 57.6% | 122,084 |
| 2022-08-03 | 5.7M | 11.2M | 51.5% | 164,049 |
| 2022-08-02 | 1.7M | 4.5M | 38.7% | 41,015 |
| 2022-08-01 | 2.0M | 4.3M | 46.3% | 57,238 |
| 2022-07-29 | 4.9M | 9.2M | 53.9% | 601,787 |
| 2022-07-28 | 3.0M | 5.9M | 51.2% | 239,466 |
| 2022-07-27 | 4.2M | 6.8M | 60.9% | 652,689 |
| 2022-07-26 | 2.3M | 5.2M | 43.5% | 296,519 |
| 2022-07-25 | 4.2M | 7.6M | 55.6% | 320,735 |
| 2022-07-22 | 7.4M | 14.5M | 51.1% | 908,270 |
| 2022-07-21 | 24.7M | 46.1M | 53.6% | 1,606,093 |
| 2022-07-20 | 7.2M | 13.4M | 53.7% | 1,048,035 |
| 2022-07-19 | 4.6M | 9.1M | 51.0% | 623,525 |
| 2022-07-18 | 11.6M | 26.8M | 43.2% | 1,168,696 |
| 2022-07-15 | 8.7M | 21.8M | 39.8% | 796,724 |
| 2022-07-14 | 4.5M | 9.2M | 49.3% | 256,381 |
| 2022-07-13 | 6.4M | 12.4M | 51.1% | 258,502 |
| 2022-07-12 | 9.0M | 17.0M | 52.9% | 702,963 |
| 2022-07-11 | 8.3M | 16.9M | 48.8% | 683,697 |
| 2022-07-08 | 22.3M | 40.4M | 55.2% | 620,814 |
| 2022-07-07 | 37.2M | 73.2M | 50.8% | 1,376,115 |
| 2022-07-06 | 53.6M | 101.3M | 52.9% | 1,549,693 |
| 2022-07-05 | 20.4M | 38.1M | 53.5% | 1,625,966 |
| 2022-07-01 | 16.3M | 32.3M | 50.3% | 1,345,676 |
| 2022-06-30 | 44.4M | 81.5M | 54.4% | 3,136,221 |
| 2022-06-29 | 29.7M | 58.6M | 50.7% | 2,520,426 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 17 June 2026, the fails-to-deliver balance in EVFM is 11,618 shares, down 9,401 shares over the last settlement date. Over the last 30 readings it ranged from 837 shares (2 June 2026) to 127,913 shares (7 November 2025). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-06-17 | 11,618 | n/a | n/a |
| 2026-06-16 | 21,019 | n/a | n/a |
| 2026-06-04 | 10,830 | n/a | n/a |
| 2026-06-03 | 837 | n/a | n/a |
| 2026-06-02 | 837 | n/a | n/a |
| 2026-05-28 | 1,931 | n/a | n/a |
| 2026-05-27 | 1,931 | n/a | n/a |
| 2026-05-21 | 1,054 | n/a | n/a |
| 2026-05-20 | 1,054 | n/a | n/a |
| 2026-05-11 | 7,095 | n/a | n/a |
| 2026-05-08 | 7,095 | n/a | n/a |
| 2026-04-02 | 938 | n/a | n/a |
| 2026-04-01 | 928 | n/a | n/a |
| 2026-01-08 | 47,260 | n/a | n/a |
| 2026-01-07 | 47,260 | n/a | n/a |
| 2026-01-06 | 47,329 | n/a | n/a |
| 2025-12-31 | 9,772 | n/a | n/a |
| 2025-12-30 | 35,064 | n/a | n/a |
| 2025-11-19 | 96,551 | $0.01 | $966 |
| 2025-11-18 | 96,451 | n/a | n/a |
| 2025-11-17 | 96,451 | n/a | n/a |
| 2025-11-13 | 7,232 | n/a | n/a |
| 2025-11-12 | 7,142 | n/a | n/a |
| 2025-11-07 | 127,913 | n/a | n/a |
| 2025-10-31 | 16,539 | $0.01 | $165 |
| 2025-10-30 | 16,339 | $0.01 | $163 |
| 2025-10-29 | 16,339 | $0.01 | $163 |
| 2025-10-21 | 3,455 | n/a | n/a |
| 2025-10-14 | 53,861 | $0.01 | $539 |
| 2025-09-26 | 14,763 | $0.01 | $148 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for EVFM in the last 90 days. The most recent filings are listed below. Latest filing: Zhang Yan (CFO) on 2024-01-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2024-01-12 | Zhang Yan | CFO | Sell | 104 | $0.04 | $4 | 0 |
| 2023-12-21 | Kamdar Kim P. | Director | Sell | 10 | $0.62 | $6 | 0 |
| 2022-12-31 | PELLETIER SAUNDRA L | Chief Executive Officer | Returned to company | 50K | $0.00 | $0 | 187K |
| 2022-05-27 | PELLETIER SAUNDRA L | Chief Executive Officer | Buy | 141K | $0.35 | $49K | 237K |
| 2022-02-18 | PELLETIER SAUNDRA L | Chief Executive Officer | Grant | 750K | $0.00 | $0 | 1.4M |
| 2022-02-18 | File Justin J. | Chief Financial Officer | Grant | 450K | $0.00 | $0 | 811K |
| 2022-02-18 | Fitzpatrick Alexander A | General Counsel and Secretary | Grant | 300K | $0.00 | $0 | 516K |
| 2021-12-31 | PELLETIER SAUNDRA L | Chief Executive Officer | Returned to company | 300K | $0.00 | $0 | 686K |
| 2021-12-31 | File Justin J. | Chief Financial Officer | Returned to company | 120K | $0.00 | $0 | 361K |
| 2021-12-31 | Fitzpatrick Alexander A | General Counsel and Secretary | Returned to company | 120K | $0.00 | $0 | 216K |
| 2021-12-20 | PELLETIER SAUNDRA L | Chief Executive Officer | Buy | 135K | $0.38 | $51K | 986K |
| 2021-12-20 | File Justin J. | Chief Financial Officer | Buy | 41K | $0.37 | $15K | 481K |
| 2021-12-20 | Fitzpatrick Alexander A | General Counsel and Secretary | Buy | 25K | $0.39 | $10K | 336K |
| 2021-07-08 | Barrans Russell | Chief Commercial Officer | Tax withholding | 20K | $0.98 | $20K | 449K |
| 2021-06-18 | Kamdar Kim P. | Director | Buy | 10K | $1.17 | $12K | 19K |
| 2021-06-14 | O'Brien Anthony Stephen | Director | Buy | 8K | $1.31 | $11K | 8K |
| 2021-06-11 | Barrans Russell | Chief Commercial Officer | Buy | 18K | $1.14 | $21K | 469K |
| 2021-06-11 | Rarick Lisa Dale | Director | Buy | 5K | $1.20 | $6K | 10K |
| 2021-06-10 | Fitzpatrick Alexander A | General Counsel and Secretary | Buy | 10K | $1.03 | $10K | 311K |
| 2021-06-10 | PELLETIER SAUNDRA L | Chief Executive Officer | Buy | 50K | $1.03 | $52K | 851K |
| 2021-06-10 | File Justin J. | Chief Financial Officer | Buy | 25K | $1.03 | $25K | 440K |
| 2021-05-20 | PELLETIER SAUNDRA L | Chief Executive Officer | Tax withholding | 105K | $0.86 | $91K | 801K |
| 2021-05-20 | File Justin J. | Chief Financial Officer | Tax withholding | 42K | $0.86 | $36K | 416K |
| 2021-05-20 | Culwell Kelly | Chief Medical Officer | Tax withholding | 42K | $0.86 | $36K | 273K |
| 2021-05-20 | Barrans Russell | Chief Commercial Officer | Tax withholding | 31K | $0.86 | $27K | 450K |
| 2021-05-20 | Fitzpatrick Alexander A | General Counsel and Secretary | Tax withholding | 42K | $0.86 | $36K | 301K |
| 2021-03-09 | PELLETIER SAUNDRA L | Chief Executive Officer | Buy | 45K | $2.28 | $103K | 906K |
| 2021-02-03 | Culwell Kelly | Chief Medical Officer | Grant | 200K | $0.00 | $0 | 315K |
| 2021-02-03 | Fitzpatrick Alexander A | General Counsel and Secretary | Grant | 200K | $0.00 | $0 | 344K |
| 2021-02-03 | File Justin J. | Chief Financial Officer | Grant | 200K | $0.00 | $0 | 458K |
| 2021-02-03 | Barrans Russell | Chief Commercial Officer | Grant | 200K | $0.00 | $0 | 482K |
| 2021-02-03 | PELLETIER SAUNDRA L | Chief Executive Officer | Grant | 500K | $0.00 | $0 | 861K |
| 2020-11-17 | Fitzpatrick Alexander A | General Counsel and Secretary | Buy | 9K | $2.20 | $20K | 144K |
| 2020-11-17 | File Justin J. | Chief Financial Officer | Buy | 8K | $2.17 | $17K | 258K |
| 2020-09-11 | Barrans Russell | Chief Commercial Officer | Buy | 3K | $2.08 | $6K | 279K |
| 2020-09-10 | Barrans Russell | Chief Commercial Officer | Buy | 1K | $2.71 | $3K | 276K |
| 2020-09-08 | PELLETIER SAUNDRA L | Chief Executive Officer | Sell | 123K | $3.26 | $399K | 361K |
| 2020-07-08 | Barrans Russell | Chief Commercial Officer | Tax withholding | 20K | $3.30 | $67K | 275K |
| 2020-06-17 | Rarick Lisa Dale | Director | Buy | 5K | $2.99 | $16K | 5K |
| 2020-06-15 | Hall William Walmsley | Director | Buy | 5K | $2.85 | $14K | 5K |
| 2020-06-12 | File Justin J. | Chief Financial Officer | Buy | 9K | $3.14 | $27K | 250K |
| 2020-06-12 | Kamdar Kim P. | Director,TenPercentOwner | Buy | 5K | $2.94 | $15K | 9K |
| 2020-06-05 | Fitzpatrick Alexander A | General Counsel and Secretary | Tax withholding | 32K | $3.31 | $105K | 134K |
| 2020-06-05 | Barrans Russell | Chief Commercial Officer | Tax withholding | 15K | $3.31 | $51K | 294K |
| 2020-06-05 | PELLETIER SAUNDRA L | Chief Executive Officer | Tax withholding | 86K | $3.31 | $283K | 479K |
| 2020-06-05 | Culwell Kelly | Chief Medical Officer | Tax withholding | 32K | $3.31 | $104K | 115K |
| 2020-06-05 | File Justin J. | Chief Financial Officer | Tax withholding | 43K | $3.31 | $142K | 238K |
| 2020-06-05 | Invesco Ltd. | TenPercentOwner | Buy | 857K | $3.50 | $3.0M | 13.2M |
| 2020-06-04 | Link Fund Solutions Ltd | TenPercentOwner | Sell | 9.1M | $0.23 | $2.1M | 0 |
| 2020-06-04 | ACACIA RESEARCH CORP | TenPercentOwner | Sell | 9.1M | $3.21 | $29.3M | 1K |
| 2020-05-26 | Invesco Ltd. | TenPercentOwner | Sell | 65 | $5.98 | $389 | 12.4M |
| 2020-05-26 | Invesco Ltd. | TenPercentOwner | Sell | 74K | $5.79 | $427K | 12.4M |
| 2020-05-22 | File Justin J. | Chief Financial Officer | Tax withholding | 42K | $4.99 | $211K | 280K |
| 2020-05-22 | Barrans Russell | Chief Commercial Officer | Tax withholding | 19K | $4.99 | $97K | 309K |
| 2020-05-22 | Culwell Kelly | Chief Medical Officer | Tax withholding | 39K | $4.99 | $197K | 147K |
| 2020-05-22 | Fitzpatrick Alexander A | General Counsel and Secretary | Tax withholding | 39K | $4.99 | $197K | 166K |
| 2020-05-22 | PELLETIER SAUNDRA L | Chief Executive Officer | Tax withholding | 85K | $4.99 | $422K | 565K |
| 2020-05-21 | PDL BIOPHARMA, INC. | TenPercentOwner | Other transaction | 13.3M | $0.00 | $0 | 0 |
| 2020-05-15 | Invesco Ltd. | TenPercentOwner | Sell | 3K | $5.04 | $16K | 12.4M |
| 2020-05-14 | Invesco Ltd. | TenPercentOwner | Other transaction | 78K | $5.13 | $400K | 12.4M |
| 2020-05-06 | Fitzpatrick Alexander A | General Counsel and Secretary | Tax withholding | 8K | $5.24 | $41K | 206K |
| 2020-05-06 | PELLETIER SAUNDRA L | Chief Executive Officer | Tax withholding | 17K | $5.24 | $89K | 649K |
| 2020-05-06 | File Justin J. | Chief Financial Officer | Tax withholding | 8K | $5.24 | $44K | 323K |
| 2020-05-06 | Culwell Kelly | Chief Medical Officer | Tax withholding | 8K | $5.24 | $41K | 186K |
| 2020-05-06 | Barrans Russell | Chief Commercial Officer | Tax withholding | 4K | $5.24 | $20K | 328K |
| 2020-05-01 | Culwell Kelly | Chief Medical Officer | Sell | 1K | $4.75 | $5K | 194K |
| 2020-04-30 | Culwell Kelly | Chief Medical Officer | Sell | 1K | $4.66 | $5K | 195K |
| 2020-03-31 | Lynch Thomas G | Director | Exercise or conversion | 38K | $0.00 | $0 | 325K |
| 2020-02-19 | Barrans Russell | Chief Commercial Officer | Sell | 15K | $6.50 | $97K | 332K |
| 2020-02-19 | Culwell Kelly | Chief Medical Officer | Sell | 1K | $7.00 | $7K | 196K |
| 2020-02-05 | Culwell Kelly | Chief Medical Officer | Grant | 4K | $5.21 | $19K | 47K |
| 2020-02-05 | Culwell Kelly | Chief Medical Officer | Grant | 150K | $0.00 | $0 | 197K |
| 2020-02-05 | File Justin J. | Chief Financial Officer | Grant | 150K | $0.00 | $0 | 331K |
| 2020-02-05 | File Justin J. | Chief Financial Officer | Grant | 4K | $5.21 | $20K | 181K |
| 2020-02-05 | Fitzpatrick Alexander A | General Counsel and Secretary | Grant | 150K | $0.00 | $0 | 213K |
| 2020-02-05 | PELLETIER SAUNDRA L | Chief Executive Officer | Grant | 300K | $0.00 | $0 | 666K |
| 2020-02-05 | PELLETIER SAUNDRA L | Chief Executive Officer | Grant | 4K | $5.21 | $20K | 366K |
| 2020-02-05 | Barrans Russell | Chief Commercial Officer | Grant | 899 | $5.21 | $5K | 197K |
| 2020-02-05 | Barrans Russell | Chief Commercial Officer | Grant | 150K | $0.00 | $0 | 347K |
| 2020-01-16 | Barrans Russell | Chief Commercial Officer | Sell | 2K | $6.50 | $10K | 196K |
| 2020-01-13 | PELLETIER SAUNDRA L | Chief Executive Officer | Sell | 3K | $6.00 | $20K | 362K |
| 2020-01-13 | File Justin J. | Chief Financial Officer | Sell | 2K | $6.00 | $10K | 177K |
| 2020-01-02 | File Justin J. | Chief Financial Officer | Sell | 3K | $6.05 | $20K | 179K |
| 2020-01-02 | PELLETIER SAUNDRA L | Chief Executive Officer | Sell | 7K | $6.05 | $41K | 366K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of EVFM in its latest filing, on Schedule 13D (active intent). The holder is HUB Cyber Security Ltd. at 10.0% of the class (14,709,204 shares), filed 2026-08-04 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-04 | 13D | HUB Cyber Security Ltd.corporation | 14.7M | 10.0% | 2026-06-30 |
What this page is
Evofem Biosciences in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Evofem Biosciences (EVFM), SEC CIK 1618835, listed on OTC, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2022-08-10.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-06-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-04.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-05-18.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2024-01-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 1618835Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of EVFM is sold short?
4,845 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is EVFM's daily short volume?
On 2022-08-10, 16,452,502 of the 29,800,416 EVFM shares reported to FINRA were sold short, 55.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does EVFM have fails to deliver?
The SEC's latest file shows 11,618 EVFM shares failed to deliver at settlement 2026-06-17. Fails are reported per settlement date and published twice a month with a lag.
Are EVFM insiders buying or selling?
No open-market insider trades were reported for EVFM in the last 90 days. The most recent filings are listed below. Latest filing: Zhang Yan (CFO) on 2024-01-12.
Who owns 5% or more of EVFM?
1 holder reports 5% or more of EVFM in its latest filing, on Schedule 13D (active intent). The holder is HUB Cyber Security Ltd. at 10.0% of the class (14,709,204 shares), filed 2026-08-04 for an event on 2026-06-30.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.